Simplify Propel Opportunities ETF
Simplify Propel Opportunities ETF reported 32 holdings worth US$77.3M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 24, 2026
Simplify Propel Opportunities ETF reported 32 holdings worth US$77.3M as of Jun 30, 2026. Largest: Plains Gp Holdings, L.p., Achieve Life Sciences, Inc. and Milestone Pharmaceuticals Inc. Filed Aug 24, 2026 (Form N-PORT).
- Holdings
- 32
- Value as reported
- US$77.3M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Plains Gp Holdings, L.p. | 1.27M | US$30.9M | 40.0% |
| Achieve Life Sciences, Inc. | 1.43M | US$9.35M | 12.1% |
| Milestone Pharmaceuticals Inc. | 3.35M | US$4.49M | 5.8% |
| Delcath Systems, Inc. | 261K | US$3.29M | 4.3% |
| Phathom Pharmaceuticals, Inc. | 249K | US$2.7M | 3.5% |
| Corcept Therapeutics Incorporated | 26,434 | US$2.3M | 3.0% |
| Abeona Therapeutics Inc. | 345K | US$2.13M | 2.8% |
| Celldex Therapeutics, Inc. | 53,134 | US$1.98M | 2.6% |
| Kyverna Therapeutics, Inc. | 183K | US$1.63M | 2.1% |
| Leonabio, Inc. | 149K | US$1.37M | 1.8% |
| Inventiva Sa | 313K | US$1.18M | 1.5% |
| Aquestive Therapeutics, Inc. | 279K | US$1.16M | 1.5% |
| Artiva Biotherapeutics, Inc. | 101K | US$983K | 1.3% |
| Zevra Therapeutics, Inc. | 67,372 | US$966K | 1.3% |
| Orchestra Biomed Holdings, Inc. | 219K | US$947K | 1.2% |
| Palisade Bio, Inc. | 451K | US$942K | 1.2% |
| Ocular Therapeutix, Inc. | 81,051 | US$796K | 1.0% |
| Eyepoint, Inc. | 45,409 | US$649K | 0.84% |
| Immunic, Inc. | 30,725 | US$472K | 0.61% |
| Upstream Bio, Inc. | 62,113 | US$430K | 0.56% |
| Sab Biotherapeutics, Inc. | 105K | US$409K | 0.53% |
| Ovid Therapeutics Inc. | 96,817 | US$260K | 0.34% |
| 4d Molecular Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Corvus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Connect Biopharma Holdings Limited | 0 | US$0 | 0.00% |
| Vor Biopharma Inc. | 0 | US$0 | 0.00% |
| Zealand Pharma A/s | 0 | US$0 | 0.00% |
| Trevi Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Kalaris Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Oculis Holding Ag | 0 | US$0 | 0.00% |
| Viridian Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Coherus Oncology, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related